DC
MHCAGAPW
MHJSPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Apellis Pharmaceuticalsapellis.com PYLLDE |
Apellis Pharmaceuticals is a biotechnology company founded in 2008 that develops complement science therapies to treat patients wi | Waltham, Massachusetts | 201-1000 | — |
IVERIC bioivericbio.com |
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration, with operations based i | New York, New York | 51-200 | — |
Annexon Biosciencesannexonbio.com |
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a portfolio of complement-inhibitor therapies targ | South San Francisco, California | 51-200 | — |
Alexionalexion.com  JHWWSA |
Alexion, AstraZeneca Rare Disease is a rare disease company headquartered in Boston that pioneered complement-system medicines ove | Boston, Massachusetts | 5000+ | — |
Rocheroche.com CZ  ASJB |
— | — | — | |
Biogenbiogen.com  MW LM DQ |
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class medi | Cambridge, Massachusetts | 5000+ | — |
Novartisnovartis.com JJMBRG |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
AstraZenecaastrazeneca.com  LKNMLC |
AstraZeneca is a research-based bioPharmaceutical company that develops and manufactures medicines, vaccines, and oncology treatme | — | — | — |
Genentechgenentech.com |
— | — | — | |
Regeneronregeneron.com HZ  KR FL |
Regeneron is a biopharmaceutical company that invents, develops, and commercializes life-transforming medicines for people with se | Tarrytown, New York | 5000+ | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Amgenamgen.com AC  MK RK |
Amgen is a biotechnology pioneer that uses living cells to make biologic medicines, with a research pipeline treating cancer, hear | Thousand Oaks, California | 5000+ | — |
Beam Therapeuticsbeamtx.com  JV ASGS |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Cryoport Systemscryoport.com |
Cryoport Systems is a temperature-controlled supply chain platform for the life sciences, offering shipping systems, transportatio | — | — | — |
REGENXBIOregenxbio.com |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
Appliedtherapeuticsappliedtherapeutics.com |
— | — | — | |
uniQureuniqure.com |
uniQure is a gene therapy company with a modular, validated technology platform that advances a pipeline of proprietary and partne | Amsterdam, 1105BP | 201-1000 | — |
Catalyst Biosciencescatbio.com |
Catalyst Bio is a research and clinical development biopharmaceutical company focused on rare disorders of the complement and coag | South San Francisco, California | 51-200 | — |
Alumisalumis.com |
Alumis is a biotechnology company developing lonigutamab, a late-stage anti-IGF-1R monoclonal antibody therapy with subcutaneous a | South San Francisco, California | 201-1000 | — |
Omerosomeros.com |
Omeros is a Seattle-based biopharmaceutical company that discovers, develops, and commercializes small-molecule and protein therap | Seattle, Washington | 201-1000 | — |
KALA BIOkalarx.com |
KALA BIO is a clinical-stage biopharmaceutical company developing biologics-based investigational therapies for rare and serious e | Arlington, Massachusetts | 51-200 | — |
Alimera Sciencesalimerasciences.com |
Alimera Sciences is a global pharmaceutical company focused on retinal health and diabetes, with a stated mission to be invaluable | Alpharetta, Georgia | 201-1000 | — |
Igmbioigmbio.com |
IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company developing a pipeline of IgM-based therapeutic antibodies | Mountain View, California | 51-200 | — |
Kodiak Scienceskodiak.com |
Kodiak Sciences is a retina-focused biopharmaceutical company researching, developing, and commercializing transformative therapeu | Palo Alto, California | 51-200 | — |
Oculogenexoculogenex.com |
Oculogenex is a biopharmaceutical company developing a novel investigational gene therapy to stop the degeneration of central visi | La Habra, California | 1-10 | — |
Nacuity Pharmaceuticalsnacuity.com |
Nacuity Pharmaceuticals is a clinical-stage biopharma company based in Fort Worth, TX, developing targeted prescription therapies | Fort Worth, Texas | 1-10 | — |
Gemini Therapeuticsgeminitherapeutics.com |
Gemini Therapeutics is a biopharmaceutical company focused on genetically-defined dry age-related macular degeneration (AMD) and a | Cambridge, Massachusetts | 1-10 | — |
Achillionachillion.com |
Achillion is a biopharmaceutical company focused on complement system disorders, developing therapies to treat patients and famili | New Haven, Connecticut | 51-200 | — |
Rallybiorallybio.com |
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company developing life-transforming therapies for patients with severe | New Haven, Connecticut | 11-50 | — |
Nanostherapeuticsnanostherapeutics.com |
Nanoscope Therapeutics develops MCO-010, the first and only broad spectrum, fast response, ultra-sensitive optogenetic therapy for | Dallas, Texas | 11-50 | — |
| Run live for more | ||||
Apellis Pharmaceuticals is a biotechnology company founded in 2008 that develops complement science therapies to treat patients with debilitating diseases; it has been acquired by Biogen and is now part of Biogen.
Companies like Apellis Pharmaceuticals include IVERIC bio, Annexon Biosciences, Alexion, Roche, Biogen. See the full list of 24 competitors and alternatives above.
Apellis Pharmaceuticals has approximately 201-1000 employees and is in the Biotechnology Research industry.
Apellis Pharmaceuticals is headquartered in Waltham, Massachusetts.
Apellis Pharmaceuticals operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Apellis Pharmaceuticals are listed above, including leaders across executive, finance, sales and operations.